Perspective Therapeutics (CATX) Change in Acquisitions & Divestments (2015 - 2026)

Perspective Therapeutics has reported Change in Acquisitions & Divestments for 10 years, with the latest figure at $47.6 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 119.5% year-over-year to $47.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $199.9 million (up 99.02% YoY) and the FY2025 annual result came in at $174.0 million, up 120.95% from the prior year.
• Change in Acquisitions & Divestments declined to $47.6 million in Q1 2026 per CATX's latest filing, from $174.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $174.0 million in Q4 2025 and troughed at -$21.7 million in Q2 2025.
• A 5-year average of $47.9 million and a median of $22.8 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2025 and 2026: Change in Acquisitions & Divestments soared 120.95% in 2025, then jumped 119.5% in 2026.
• Over 5 years, Change in Acquisitions & Divestments stood at $12.5 million in 2022, then soared by 81.56% to $22.8 million in 2023, then surged by 245.85% to $78.7 million in 2024, then jumped by 120.95% to $174.0 million in 2025, then plunged by 72.61% to $47.6 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $47.6 million, $174.0 million, and -$21.7 million for Q1 2026, Q4 2025, and Q2 2025 respectively.